Daten, die bei TCT Connect vorgestellt worden sind, zeigen, dass ein Prä-PCI-Einsatz von Impella bei akutem Myokardinfarkt mit kardiogenem Schock zu einer höheren Überlebensrate führt – insbesondere bei Frauen

Attention subscribers

We have recently launched a new and improved website. To continue reading, you will need to either log into your subscriber account, or purchase a new subscription.

If you are a digital subscriber with an active subscription, then you already have an account here. Just reset your password if you've not yet logged in to your account on this new site.

If you are a current print subscriber, you can set up a free website account by clicking here.

Otherwise, click here to view your options for subscribing.